Search research articles
Contact Us
Filters
Showing results (121-130 of 248) with videos related to
Page
of 25
Sort By:
Clinical Nephrology
|
February 25, 2015
An unusual case of acute kidney injury - idiopathic granulomatous tubulointerstitial nephritis
Olga Balafa, Georgios Liapis, Anila Duni, et al.
Journal of Clinical Lipidology
|
May 27, 2017
Sitosterolemia: A multifaceted metabolic disorder with important clinical consequences
Eleftheria Tzavella, Eleftheria Hatzimichael, Christina Kostara, et al.
Clinical Chemistry
|
June 29, 2002
Rhabdomyolysis-related renal tubular damage studied by proton nuclear magnetic resonance spectroscopy of urine
Eleni Bairaktari, Konstantin Seferiadis, George Liamis, et al.
Oncology
|
August 22, 2003
Successful treatment of human immunodeficiency virus-related Castleman's disease: a case report and literature review
Evagelos Liberopoulos, Christos Tolis, Mary Bai, et al.
Archives of Medical Sciences. Atherosclerotic Diseases
|
December 16, 2017
No effect of vitamin D supplementation on cardiovascular risk factors in subjects with metabolic syndrome: a pilot randomised study
Stefania E Makariou, Moses Elisaf, Anna Challa, et al.
European Journal of Clinical Investigation
|
April 23, 2013
Effect of hypolipidemic treatment on emerging risk factors in mixed dyslipidemia: a randomized pilot trial
Anastazia Kei, Evangelos Liberopoulos, Kostantinos Tellis, et al.
Journal of Lipid Research
|
October 5, 2013
The elevation of apoB in hypercholesterolemic patients is primarily attributed to the relative increase of apoB/Lp-PLA₂
Constantinos C Tellis, Eliza Moutzouri, Moses Elisaf, et al.
Journal of Cardiovascular Pharmacology and Therapeutics
|
September 3, 2009
Efficacy and safety of ezetimibe plus orlistat or rimonabant in statin-intolerant nondiabetic overweight/obese patients with dyslipidemia
Matilda Florentin, Michael S Kostapanos, Eleni S Nakou, et al.
Journal of Cardiovascular Pharmacology and Therapeutics
|
March 21, 2012
Effect of rosuvastatin monotherapy and in combination with fenofibrate or omega-3 fatty acids on serum vitamin D levels
Stefania E Makariou, Evangelos N Liberopoulos, Aris P Agouridis, et al.
Journal of Cardiovascular Pharmacology and Therapeutics
|
December 20, 2002
Effect of ciprofibrate on lipoproteins, fibrinogen, renal function, and hepatic enzymes
Evangelos Rizos, Eleni Bairaktari, Emmanouel Ganotakis, et al.
Page
of 25
Search research articles
Search
Showing results (121-130 of 248) with videos related to
Sort By:
Page
of 25
Clinical Nephrology
|
February 25, 2015
An unusual case of acute kidney injury - idiopathic granulomatous tubulointerstitial nephritis
Olga Balafa, Georgios Liapis, Anila Duni, et al.
Journal of Clinical Lipidology
|
May 27, 2017
Sitosterolemia: A multifaceted metabolic disorder with important clinical consequences
Eleftheria Tzavella, Eleftheria Hatzimichael, Christina Kostara, et al.
Clinical Chemistry
|
June 29, 2002
Rhabdomyolysis-related renal tubular damage studied by proton nuclear magnetic resonance spectroscopy of urine
Eleni Bairaktari, Konstantin Seferiadis, George Liamis, et al.
Oncology
|
August 22, 2003
Successful treatment of human immunodeficiency virus-related Castleman's disease: a case report and literature review
Evagelos Liberopoulos, Christos Tolis, Mary Bai, et al.
Archives of Medical Sciences. Atherosclerotic Diseases
|
December 16, 2017
No effect of vitamin D supplementation on cardiovascular risk factors in subjects with metabolic syndrome: a pilot randomised study
Stefania E Makariou, Moses Elisaf, Anna Challa, et al.
European Journal of Clinical Investigation
|
April 23, 2013
Effect of hypolipidemic treatment on emerging risk factors in mixed dyslipidemia: a randomized pilot trial
Anastazia Kei, Evangelos Liberopoulos, Kostantinos Tellis, et al.
Journal of Lipid Research
|
October 5, 2013
The elevation of apoB in hypercholesterolemic patients is primarily attributed to the relative increase of apoB/Lp-PLA₂
Constantinos C Tellis, Eliza Moutzouri, Moses Elisaf, et al.
Journal of Cardiovascular Pharmacology and Therapeutics
|
September 3, 2009
Efficacy and safety of ezetimibe plus orlistat or rimonabant in statin-intolerant nondiabetic overweight/obese patients with dyslipidemia
Matilda Florentin, Michael S Kostapanos, Eleni S Nakou, et al.
Journal of Cardiovascular Pharmacology and Therapeutics
|
March 21, 2012
Effect of rosuvastatin monotherapy and in combination with fenofibrate or omega-3 fatty acids on serum vitamin D levels
Stefania E Makariou, Evangelos N Liberopoulos, Aris P Agouridis, et al.
Journal of Cardiovascular Pharmacology and Therapeutics
|
December 20, 2002
Effect of ciprofibrate on lipoproteins, fibrinogen, renal function, and hepatic enzymes
Evangelos Rizos, Eleni Bairaktari, Emmanouel Ganotakis, et al.
Page
of 25